Human ion channel proteins

Bibliographic Details
Title: Human ion channel proteins
Patent Number: 7,067,626
Publication Date: June 27, 2006
Appl. No: 09/899495
Application Filed: July 05, 2001
Abstract: The present invention provides novel ion channel polypeptides and polynucleotides that identify and encode them. In addition, the invention provides expression vectors, host cells and methods for their production. The invention also provides methods for the identification of ion channel agonists/antagonists, useful for the treatment of human diseases and conditions.
Inventors: Benjamin, Christopher W. (Kalamazoo, MI, US); Roberds, Steven L. (Mattawan, MI, US); Karnovsky, Alla M. (Kalamazoo, MI, US); Ruble, Cara L. (Paw Paw, MI, US)
Assignees: Pharmacia & Upjohn Company (Kalamazoo, MI, US)
Claim: 1. An isolated polypeptide that comprises SEQ ID NO: 116.
Current U.S. Class: 530/350
Patent References Cited: 4399216 August 1983 Axel et al.
4683195 July 1987 Mullis et al.
4683202 July 1987 Mullis
4879236 November 1989 Smith et al.
5202231 April 1993 Drmanac et al.
5521065 May 1996 Whiteley et al.
5585277 December 1996 Bowie et al.
0 367 566 May 1990
WO 91/09955 July 1991
WO 91/18982 December 1991
WO 92/20808 November 1992
WO 93/11236 June 1993
WO 94/12650 June 1994
WO 95/20652 August 1995
WO 96/22976 August 1996
WO 97/09433 March 1997
WO 98/37177 August 1998
WO99/32615 July 1999
WO01/44283 June 2001
WO01/68849 September 2001






































































































































Other References: Skolnick et al. Trends in Biotech. 18:34-39, 2000. cited by examiner
Bork P. Genome Research 10:398-400, 2000. cited by examiner
Doerks et al. Trends in Genetics 14:248-250, 1998. cited by examiner
Smith et al. Nature Biotechnology 15:1222-1223, 1997. cited by examiner
Brenner SE. Trends in Genetics 15:132-133, 1999. cited by examiner
Bork et al. Trends in Genetics 12:425-427, 1996. cited by examiner
Ayala FJ and Kiger JA. Multiple Alleles. In Modern Genetics. The Benjamin/Cummings Publishing Co., Inc. Reading, Massachusetts. pp. 45-48, 1980. cited by examiner
Rieger R, et al. Glossary of Genetics:Classical and Molecular. 5th ed. Springer-Verlag. New York. pp. 16-17, 1991. cited by examiner
Akane, A., et al., “direct dideoxy sequencing of genomic DNA by ligation-mediated PCR,” Biotechniques, 1994, 16(2), 238-241 (p. 239—advertisement). cited by other
Altschul, S. F., et al., “Basic local alignment search tool,” J. Mol. Biol., 1990, 215, 403-410. cited by other
Altschul, S. F., et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research, 1997, 25(17), 3389-3402. cited by other
American Veterinary Medical Association, Report of the American Veterinary Medical Assoc., Panel on Euthanasia, Journal of American Veterinary Medical Assoc., 1993, 202, 229-249. cited by other
Anderson, W. F., “Human gene therapy,” Science , 1992, 256, 808-813. cited by other
Anderson, W.F., “Human gene therapy,” Nature, Supplement to vol. 392(6679), 1998; 25-30. cited by other
Aukrust, P., et al., “Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina; Possible Reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes,” Circulation, 1999, 100, 614-620. cited by other
Ausubel, et al. (Eds.), “Chapter 6, Screening of recombinant DNA libraries,” Current Protocols in Molecular Biology, 1994, John Wiley & Sons, 6.0.1-6.4.10. cited by other
Ausubel, et al. (Eds.), Current Protocols in Molecular Biology, New York, 1987-1999, John Wiley & Sons, Inc. cited by other
Ausubel, F. M., et al., Short Protocols in Molecular Biology, 4th Ed., 1992, Greene & Wiley-Interscience, New York. cited by other
Baindur, N., et al., “Selective fluorescent ligands for pharmacological receptors,” Drug Dev. Res., 1994, 33, 373-398. cited by other
Benoist C., et al., “In vivo sequence requirements of the SV40 early promoter region,” Nature, 1981, 290, 304-310. cited by other
Berger, et al., Guide to Molecular Cloning Techniques, Methods in Enzymology 152, 1987, Academic Press, Inc., San Diego, CA. cited by other
Bossé, R., et al., “Development of nonseparation binding and functional assays for G protein-coupled receptors for high throughput screening: Pharmacological characterization of the immobilized CCR5 receptor on FlashPlate®,” J. Biomolecular Screening, 1998, 3(4), 285-292. cited by other
Breeden, L., et al., “Regulation of the yeast HO gene,” Cold Spring Harb. Symp. Quant. Biol., 1985, vol. L, Molecular Biology of Development, 643-650. cited by other
Broeck, V., “G-protein-coupled receptors in insect cells,” Int. Rev. Cytology, 1996, 164, 189-268. cited by other
Capecchi, M. R., “Altering the genome by homologous recombination,” Science, 1989, 244, 1288-1292. cited by other
Chambers, R. C., et al., “Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1,” Biochem J., 1998, 333, 121-127. cited by other
Choo, Y., et al., “Promoter-specific activation of gene expression directed by bacteriophage-selected zinc fingers,” J. Mol. Biol., 1997, 273, 525-532. cited by other
Cicala, C., et al., “Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea-pigs in vivo,” Br. J. Pharmacol, 1999, 126, 478-484. cited by other
Cirino, G., et al., “Thrombin functions as an inflammatory mediator through activation of its receptor,” J. Exp. Med., 1996, 183, 821-827. cited by other
Cobbold, et al., “Aequorin measurements of cytoplasmic free calcium,” In: McCormack J.G., et al. (Eds.), Cellular Calcium: A Practical Approach, 1991, Oxford, IRL Press. cited by other
Colotta, F., et al., “Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin,” Am. J. Pathol, 1994, 144, 975-985. cited by other
Cosman, D., et al., “Cloning, sequence and expression of human interleukin-2 receptor,” Nature, 1984, 312, 768-771. cited by other
Cosman, D., et al., “High Level Stable Expression of Human Interleukin-2 receptors in Mouse Cells Generates only Low Affinity Interleukin-2 Binding Sites,” Mol. Immunol., 1986, 23(9), 935-941. cited by other
Current Protocols in Molecular Biology, 1999, John Wiley & Sons, New York. cited by other
Cutting, G. R., “Cloning of the γ-aminobutyric acid (GABA) ρ1cDNA: A GABA receptor subunit highly expressed in the retina,” Proc. Natl. Acad. Sci. USA, Apr. 1991, 88, 2673-2677. cited by other
Dayoff, in Atlas of Protein Sequence and Structure, 1972, National Biochemical Research Foundation, Washington, D.C., 5, 124. cited by other
DiCuccio, M. N., et al., “A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells,” Exp. Hematol, 1996, 24, 914-918. cited by other
Donovan, F. M., et al., “Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosin kinase and RhoA activities,” J. Neurosci, 1997, 17(14), 5316-5326. cited by other
Douglas, A. M., et al., “Direct sequencing of double-stranded PCR products incorporating a chemiluminescent detection procedure,” Biotechniques, 1993, 14, 824-828. cited by other
Drmanac, S., et al., “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,” Nature Biotechnology, 1998, 16, 54-58. cited by other
Dunlop, J., et al., “Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer,” J. Pharmacological and Toxicological Methods, 1998, 40(1), 47-55. cited by other
Eisenthal, R., et al. (Eds.) In Enzyme Assays, A Practical Approach, 1992, Oxford University Press. cited by other
Fields, S., et al., “A novel genetic system to detect protein-protein interactions,” Nature, 1989, 340, 245-246. cited by other
Fields, S., et al., “The two-hybrid system: an assay for protein-protein interactions,” Trends in Genetics, 1994, 10(8), 286-292. cited by other
Fink, M. et al., “Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+channel,” The EMBO Journal, 1996, 15(24), 6854-6862. cited by other
Fischer, S. G., et al., “DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory,” Proc. Natl. Acad. Sci. USA, 1983, 80, 1579-1583. cited by other
Friedmann, T., “Progress toward human gene therapy,” Science, 1989, 244, 1275-1281. cited by other
Gerhardt, C. C., et al., “Functional characteristics of heterologously expressed 5-HT receptors,” Eur. J. Pharmacology, 1997, 334, 1-23. cited by other
Gill, J. S., et al., “Thrombin induced inhibition of neurite outgrowth from dorsal root ganglion neurons,” Brain Res., 1998, 797, 321-327. cited by other
Greisman, H. A., et al., “A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites,” Science, 1997, 275, 657-661. cited by other
Harlow, et al. (Eds.), Antibodies A Laboratory Manual, 1988, Cold Spring Harbor Laboratory; Cold Spring Harbor, New York. cited by other
Hauck, R. W., et al., “α-thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors,” Am J. Physiol, 1999, 277, L22-L29. cited by other
Haugland, Handbook of Fluorescent probes and Research Chemicals, 6th Ed., 1996, Eugene OR: Molecular Probes. cited by other
Henikoff, S., et al., “Amino acid substitution matrices from protein blocks,” Proc. Natl. Acad. Sci. USA, 1992, 89, 10915-10919. cited by other
Hershey, A. D., (Ed.), The Bacteriophage Lambda, 1973, Cold Spring Harbor Press, Cold Spring Harbor, New York. cited by other
Hill, D. C., “Trends in development of high-throughput screening technologies for rapid discovery of novel drugs,” Cur. Opinion Drug Disc. Dev., 1998, 1(1), 92-97. cited by other
Hodgson, J., “Receptor screening and the search for new pharmacteuticals,” Bio/Technology, 1992, 10, 973-980. cited by other
Hoffman, M., et al., “Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms,” Blood Cells Mol Dis, 1995, 21, 156-167. cited by other
Jan, L. Y. et al., “Voltage-gated and inwardly rectifying potassium channels,” J. of Physiology, 1997, 505(2), 267-282. cited by other
Jayawickreme, C. K., et al., Gene expression systems in the development of high-throughput screens, Current Opinion in Biotechnology, 1997, 8, 629-634. cited by other
Karlin, S., et al., “Applications and statistics for multiple high-scoring segments in molecular sequences,” Proc. Natl. Acad. Sci. USA, 1993, 90, 5873-5877. cited by other
Kieleczawa, J., et al., “DNA sequencing by primer walking with strings of contiguous hexamers,” Science, 1992, 258, 1787-1791. cited by other
Kim, J., et al., “Design of TATA box-binding protein/zinc finger fusions for targeted regulation of gene expression,” Proc. Natl. Acad. Sci. USA, 1997, 94, 3616-3620. cited by other
Krogh, A. et al., “Hidden Markov Models in Computational Biology,” J. Mol. Biol., 1994, 253, 1501-1531. cited by other
Kruse et al. (eds.), in Tissue Culture, Academic Press, 1973. cited by other
Kuntzweiler, T. A., et al., “Rapid assessment of ligand actions with nicotinic acetylcholine receptors using calcium dynamics and FLIPR,” Drug Development Research, 1998, 44(1), 14-20. cited by other
Lehninger, “Chapter 4, The amino acid building blocks of proteins,” Biochemistry, 2nd Ed., 1975, Worth Publishers, Inc., New York, New York, 71-77. cited by other
Lesage et al., Potassium ion channels, molecular structure, function, and diseases, Current topics in Membranes, 1999, 46, pp. 199-222. cited by other
Levin, E. D. et al., “AR-R 17779, an α 7 nicotinic agonist, improves learning and memory in rats,” Behavioural Pharmacology, 1999, 10 (6/7), 675-780. cited by other
Lin, A. H., et al., “The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin,” Antimicrobial Agents and Chemotherapy, 1997, 41(10), 2127-2131. cited by other
D.I. Wallis., Electrophysiology, A practical approach , IRL Press @ Oxford University Press, 1993. cited by other
Liu, Q., et al., “Design of polydactyl zinc-finger proteins for unique addressing within complex genomes,” Proc. Natl. Acad. Sci. USA, 1997, 94, 5525-5530. cited by other
Lodish et al., Molecular Cell Biology, 1997, ISBN:0-7167-2380-8. cited by other
Luckow, V. A., et al., “High Level Expression of Nonfused Foreign Genes with Autographa californica Nuclear Polyhedrosis Virus Expression Vectors,” Virology, 1989, 170, 31-39. cited by other
Luckow, V. A., et al., “Trends in the development of baculovirus expression vectors,” Bio/Technology, 1988, 6, 47-55. cited by other
Mahajan, N. P. et al., “Bcl-2 and Bax interactions in mitochondria probed with green fluorescent protein and fluorescence resonance energy transfer,” Nature Biotechnology, Jun. 1998, 16, 547-552. cited by other
Maxam, A. M., et al., “Sequencing end-labeled DNA with bse-secific chemical cleavages,”, Meth. Enzymol., 1977, vol. 65, 499-560. cited by other
McColl, D. J., et al., “Structure-based design of an RNA-binding zinc finger”, Proc. Natl. Acad. Sci. (USA), 1997, vol. 96, 9521-9526. cited by other
Miller, A. D., “Human gene therapy comes of age”, Nature, 1992, vol. 357, pp. 455-460. cited by other
Mirzabekov, A. D., “DNA sequencing by hybridization—A megasequencing method and a diagnostic tool?”, TIBTECH, 1994, vol. 12, 27-32. cited by other
Morris, R., et al., “Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue”, Ann. Rheum. Dis., 1996, vol. 55, 841-843. cited by other
Murphy, A. J., et al., “From DNA to drugs: the orphan G-protein coupled receptors,” Cur. Opinion Drug Disc. Dev., 1998, 1(2), 192-199. cited by other
Myers, R. M., et al., “Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA: DNA duplexes”, Science, 1985, vol. 230,1242-1246. cited by other
Myers, P., “Will combinatorial chemistry deliver real medicines,” Curr. Opin. Biotechnology, 1997, 8, 701-707. cited by other
Nakayama, G. R., “Microplate assays for high-throughput screening,” Cur. Opinion Drug Disc. Dev., 1998, 1(1), 85-91. cited by other
Naldini, A., et al., “Thrombin modulation of natural killer activity in human peripheral lymphocytes,” Cell Immunol, 1996, 172, 35-42. cited by other
Okayama, H., et al., “A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells,” Mol. Cell. Biol., 1983, 3(2), 280-289. cited by other
Orita, M., et al., “Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms,” Proc. Natl. Acad. Sci. USA, 1989, 86, 2766-2770. cited by other
Osol, A. (Ed.), Remington's Pharmaceutical Sciences, 16th Ed., 1980. cited by other
Parodi, L. A., et al., “A consensus procedure for predicting the location of α-helical transmembrane segments in proteins,” Comput. Appl. Biosci., 1994, 10(5), 527-535. cited by other
Pastinen, T., et al., “Minisequencing: A specific tool for DNA analysis and diagnostics on oligonucleotide arrays,” Genome Res., 1997, 7, 606-614. cited by other
Patel, A. J. et al., “Inhalational anesthetic activate two-pore-domain background K+ channels”, Nature Neuroscience, 1999, 2, pp. 422-426. cited by other
Pausch, M. H., “G-protein-coupled receptors in saccharomyces cerevisiae: high-throughput screening assays for drug discovery,” Trends in Biotechnology, 1997, 15, 487-494. cited by other
Pease, A. C., et al., “Light-generated oligonucleotide arrays for rapid DNA sequence analysis,” Proc. Natl. Acad. Sci. USA, 1994, 91, 5022-5026. cited by other
Pindon, A., et al., “Thrombin-induced reversal if astricyte stellation is mediated by activation of protein kinase C β-1,” Eur. J. Biochem., 1998, 255, 766-774. cited by other
Ramsay, G., “DNA chips: state-of-the-art,” Nature Biotechnology, 1999, 16, 40-48. cited by other
Riesner, D., et al., “Temperature-gradient gel electrophoresis of nucleic acids: Analysis of conformational transitions, sequence variations, and protein-nucleic acid interactions,” Electrophoresis, 1989, 10, 377-389. cited by other
Roberts, E., et al., “Potassium permanganate and tetraethylammonium chloride are a safe and effective substitute for osmium tetroxide in solid-phase fluorescent chemical cleavage of mismatch,” Nucl. Acids Res., 1997, 25(16), 3377-3378. cited by other
Rogers, M. V., “Light on high-throughput screening: fluorescence-based assay technologies,” Drug Discovery Today, 1997, 2(4), 156-160. cited by other
Rowley, G., et al., “Ultrarapid mutation detection by multiplex solid-phase chemical cleavage,” Genomics, 1995, 30, 574-582. cited by other
Salkoff, L. et al., “Surfing the DNA Databases for K+ Channels Nets Yet More Diversity,” Neuron, Sep. 1995, 15, 489-492. cited by other
Sambrook, et al., (Eds.), Molecular Cloning: A Laboratory Manual, 1989, Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 9.47-9.51. cited by other
Sambrook, et al., Antibodies A Laboratory Manual, 1989, Cold Spring Harbor Laboratory; Cold Spring Harbor, New York. cited by other
Sanger, F., et al., “DNA sequencing with chain-terminating inhibitors,” Proc. Natl. Acad. Sci. USA, 1977, 74(12), 5463-5467. cited by other
Drmanac, R., et al., “DNA Sequence Determination by Hybridization A Strategy for Efficient Large-Scale Sequencing,” Science, 1993, 260, 1649-1652 (sequencing by hybridization). cited by other
Schaefer, A. J. et al., “DNA variation and the future of human genetics,” Nature Biotechnology, Jan. 1998, 16, 33-39. cited by other
Schroeder, K. S., et al., “FLIPR: A new instrument for accurate, high throughput optical screening,” J. Biomolecular Screening, 1996, 1(2), 75-80. cited by other
Segal, D. J., et al., “Toward controlling gene expression at will: Selection and design of zine finger domains recognizing each of the 5′-GNN-3′ DNA target sequences,” Proc. Natl. Acad. Sci. USA, 1999, 96, 2758-2763. cited by other
Shimada, S. et al., “γ-Aminobutyric Acid A or C Receptor? γ-Aminobutyric Acid ρ1 Receptor RNA Induces Bicuculline-, Barbiturate-, and Benzodiazepine-Insensitive γ-Aminobutyric Acid Responses in Xenopus Oocytes,” Molecular Pharmacology, 1992, 41, 683-687. cited by other
Shumaker, J. M., et al., “Mutation detection by solid phase primer extension,” Hum. Mutat., 1996, 7, 346-354. cited by other
Smith, T. F., et al., “Comparison of biosequences,” Adv. Appl. Math., 1981, 2, 482-489. cited by other
Smith et al., Voltage and patch clamping with microelectrodes, Waverly Press, Inc., for the American Physiology Society, (1985). cited by other
Smith-Swintosky, V. L., et al., “Protease-activated receptor-2 (PAR-2 is present in the rat hippocampus and is associated with neurodegeneration,” J. Neurocham, 1997, 69, 1890-1896. cited by other
Stables, J., et al., “A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor,” Analytical Biochemistry, 1997, 252, 115-126. cited by other
Strosberg, et al., “Functional expression of receptors in microorganisms,” Trends in Pharmacological Sciences, 1992, 13, 95-98. cited by other
Suidan, H. A., et al., “The thrombin receptor in the nervous system,” Semin Thromb Hemost, 1996, 22(2), 125-133. cited by other
Summers, et al., A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures, Texas Agricultural Experimental Station Bulletin No. 1555, 1987, 2-46. cited by other
Sweetnam, P. M., et al., “The role of receptor binding in drug discovery,” J. Natural Products, 1993, 56(4), 441-455. cited by other
Trejo, J., et al., “The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts,” J. Biol. Chem., 1996, 271, 21536-21541. cited by other
Tsien R. Y., “The Green Fluorscent Protein,” Annu. Rev. Biochem., 1998, 67, 509-544. cited by other
Turgeon, V. L., et al., “Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation,” J. Neurosci, 1998, 18(17), 6882-6891. cited by other
Ubl, J. J., et al., “Characteristics of thrombin-induced calcium signals in rat astrocytes,” Glia, 1997, 21, 361-369. cited by other
Grabham, P., et al., Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation, J. Neurochem, 1995, 64, 583-591. cited by other
Verma, I. M., “Gene therapy,” Scientific American, 1990, 68-84 (pp. 73-80 and 83 are advertisements). cited by other
Wahlestedt, C. et al., “Potent and nontoxic antisense oligonucleotides containing locked nucleic acids,” PNAS, May 9, 2000, 97(10), 5633-5638. cited by other
White, M. B., et al., “Detecting single base substitutions as heteroduplex polymorphisms,” Genomics, 1992, 12, 301-306. cited by other
Wieboldt, R., et al., “Immunoaffinity ultrafiltration with ion spray HPLC/MS for screening small-molecule libraries,” Anal. Chem., 1997, 69(9), 1683-1691. cited by other
Williams, M., “Receptor binding in the drug discovery process,” Medicinal Research Reviews, 1991, 11(2), 147-184. cited by other
Wu, H., et al., “Building zinc fingers by selection: toward a therapeutic application,” Proc. Natl. Acad. Sci. USA, 1995, 92, 344-348. cited by other
Birren, et al., EMBL Acc. No. AC011116, Oct. 6, 1999. cited by other
Deneris, et al., “Beta3: A New Member of Nicotinic Acetylcholine Receptor gene Family Is Expressed in Brain,” J. Biol. Chem. (1989) 264(11):6266-6272. cited by other
Cooper, et al., “Ion channel genes and human neurological disease: Recent progress, prospects and ,” Proc. Natl. Acad. Sci. USA (1999) 96:4759-4766. cited by other
Adams, et al., EMBL Acc. No. AQ315444, Dec. 23, 1998. cited by other
Miyake et al., “Molecular Cloning of Human 5-Hydroxytryptamine-3 Receptor: Heterogeneity in Distribution and Function Among Species,” Mol. Pharmacol. (1995) 48(3):407-416. cited by other
John E. Macor et al., “The 5HT3 Antagonist Tropisetron NICS (205-930) is a Potent and Selective Alpha7 Nicotinic Receptor Partial Agonist”, Bioorganic & Medicinal Chemistry Letters, Oxford, GB, 11, pp. 319-321 (2001), XP001120243. cited by other
Primary Examiner: Landsman, Robert S.
Attorney, Agent or Firm: Zelson, Steve
Donahue, E. Victor
Accession Number: edspgr.07067626
Database: USPTO Patent Grants
More Details
Language:English